Axsome Therapeutics, Inc. (AXSM)
204.90
+6.38
(+3.21%)
USD |
NASDAQ |
Sep 01, 12:59
Axsome Therapeutics Cash from Operations (TTM) : -71.26M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -71.26M |
| March 31, 2026 | -70.73M |
| December 31, 2025 | -93.40M |
| September 30, 2025 | -100.95M |
| June 30, 2025 | -120.63M |
| March 31, 2025 | -118.32M |
| December 31, 2024 | -128.41M |
| September 30, 2024 | -132.57M |
| June 30, 2024 | -167.49M |
| March 31, 2024 | -192.73M |
| December 31, 2023 | -145.08M |
| September 30, 2023 | -142.28M |
| June 30, 2023 | -111.49M |
| March 31, 2023 | -89.68M |
| December 31, 2022 | -116.51M |
| September 30, 2022 | -118.10M |
| June 30, 2022 | -122.12M |
| March 31, 2022 | -113.97M |
| December 31, 2021 | -108.54M |
| September 30, 2021 | -99.94M |
| Date | Value |
|---|---|
| June 30, 2021 | -88.90M |
| March 31, 2021 | -82.40M |
| December 31, 2020 | -78.46M |
| September 30, 2020 | -75.47M |
| June 30, 2020 | -70.36M |
| March 31, 2020 | -60.15M |
| December 31, 2019 | -46.38M |
| September 30, 2019 | -38.60M |
| June 30, 2019 | -33.89M |
| March 31, 2019 | -32.87M |
| December 31, 2018 | -30.05M |
| September 30, 2018 | -26.55M |
| June 30, 2018 | -27.09M |
| March 31, 2018 | -26.52M |
| December 31, 2017 | -26.47M |
| September 30, 2017 | -27.40M |
| June 30, 2017 | -25.75M |
| March 31, 2017 | -23.97M |
| December 31, 2016 | -21.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Eli Lilly & Co. | 28.08B |
| Liquidia Corp. | 167.71M |
| Filana Therapeutics, Inc. | -28.70M |
| CorMedix, Inc. | 253.62M |
| Eloxx Pharmaceuticals, Inc. | -- |